Michael A Gillette, M.D., Ph.D.


Clinicn Investigator, Assc Prf
Pulmonary, Mass General Research Institute
Associate Professor of Medicine
Harvard Medical School
Associate Physician
Medicine-Pulmonary and Critical Care Medicine, Massachusetts General Hospital
PhD Harvard Medical School 1995
MD Harvard Medical School/ BWH 1995
MA Oxford University 1984
biological markers; blood volume; body weight; chloride channels; critical care; heparin; heterocyclic compounds 3-ring; hiv integrase inhibitors; insufflation; lung injury; mass spectrometry; phenethylamines; proteome; proteomics; respiration artificial; veterans Michael Gillette is a Senior Group Leader and Principal Investigator in the Proteomics Group at the Broad Insitituge of MIT and Harvard, an attending physician in Pulmonary and Critical Care Medicine at MGH, and an Associate Professor of Medicine at Harvard Medical School. He has led numerous national and international projects in cancer proteogenomics under the auspices of the Clinical Proteomics Tumor Analysis Consortium of the National Cancer Institute, as well as multiple biolarmer projects for diseases of clinical and public health importance including cancers, tuberculosis, and pediatric pneumonia. He serves on steering committees for multiple large consortium projects funded through NIH and private philanthropy, and is an Associate Editor for Molecular and Cellular Proteomics.